Metabolically Engineered Cells for Oligosaccharide Mixture Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing oligosaccharide mixtures are inefficient and costly, often resulting in the synthesis of a single oligosaccharide due to challenges in stereospecificity and regioselectivity of glycosyltransferases, and require laborious chemical synthesis or purification from natural sources.
Innovation Solution
A method involving metabolically engineered cells that express glycosyltransferases and synthesize nucleotide-sugars, cultivated with multiple acceptors to produce a mixture of at least two oligosaccharides, followed by separation of individual oligosaccharides from the mixture.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis methods are used for oligosaccharide production, then oligosaccharides can be produced, but the process becomes laborious and time-consuming with difficulty in scaling up
Solution Approach 1:
The patent replaces chemical synthesis methods with a biological system (metabolically engineered cells) that naturally perform oligosaccharide synthesis through metabolic pathways. This substitution of mechanical/chemical processes with a biological system resolves the contradiction by enabling scalable production without the laborious steps inherent in chemical synthesis
Solution Approach 2:
The metabolically engineered cells autonomously synthesize oligosaccharides using their own metabolic machinery. The cells self-regulate the synthesis process, managing nucleotide-sugar donor availability and glycosyltransferase activity internally, which eliminates the need for complex external chemical synthesis procedures
2Ease of manufacture
If enzymatic approaches using glycosyltransferases are used, then oligosaccharides can be synthesized with fewer steps, but stereosspecificity and regioselectivity remain formidable challenges
Solution Approach 1:
The patent introduces specific glycosyltransferase enzymes with defined stereospecificity and regioselectivity into the metabolic pathway. Each enzyme is strategically placed to perform a specific glycosylation step with precise stereochemical control, ensuring that only the desired stereoisomers and regioisomers are produced while maintaining pathway simplicity
Solution Approach 2:
The patent optimizes cellular parameters including pH, temperature, and substrate concentration to enhance the stereospecificity and regioselectivity of glycosyltransferases. By controlling the cellular environment, the enzymes achieve higher precision in oligosaccharide synthesis while maintaining the simplicity of the biological system
3Productivity
If cellular production of oligosaccharides is used, then tight control of spatiotemporal availability of nucleotide-sugar donors is needed, but current methods often result in synthesis of a single oligosaccharide instead of a mixture
Solution Approach 1:
The patent divides the oligosaccharide synthesis pathway into multiple parallel branches, each producing a different oligosaccharide product. The metabolic pathway is segmented into distinct glycosylation steps with different acceptor substrates, allowing simultaneous production of multiple oligosaccharides from a single engineered cell system
Solution Approach 2:
The metabolically engineered cell is designed to perform multiple functions simultaneously: it produces various nucleotide-sugar donors through its metabolic pathways and uses multiple glycosyltransferases to synthesize different oligosaccharides from common acceptors. This multi-functionality enables mixture production without proportionally increasing system complexity
4Quantity of substance
If purification from natural sources is used, then oligosaccharides can be obtained, but the process requires purification from complex mixtures and is not scalable
Solution Approach 1:
The engineered cells autonomously produce oligosaccharides in high yield through their metabolic pathways, eliminating the need for extraction and purification from natural sources. The cells self-generate the desired products in sufficient quantities directly in the cultivation medium, enabling scalable production without complex purification steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the efficient and cost-effective production of oligosaccharide mixtures by a single cell, overcoming the limitations of existing methods and allowing for continuous production with improved control over spatiotemporal availability of nucleotide-sugar donors.
Implementation Method 1
Glycosyltransferases catalyze the transfer of a sugar moiety from an activated nucleotide-sugar donor onto saccharide or non-saccharide acceptors
Data Source
AI summary
The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of fermentation of metabolically engineered cells. The present invention provides a method for the production of a mixture of at least two different oligosaccharides by a cell as well as the purification of at least one of said oligosaccharides from the cultivation. In addition, the present invention provides a method for the production of a mixture of at least two different oligosaccharides by a metabolically engineered cell as well as the purification of at least one of said oligosaccharides from the cultivation.